A pan-European non-interventional, retrospective observational cohort study of BRCA mutated advanced (FIGO stage III-IV) ovarian cancer patients treated with olaparib tablets in the first-line maintenance setting

Copyright © 2020 FULLCRO S.R.L. - TUTTI I DIRITTI RISERVATI - P. IVA 12073321007
per contatti riguardanti lo Studio OVAL-1 OVAL1@fullcro.org